DelveInsight's Advanced Therapy Medicinal Products Market Insights report provides the current and forecast market analysis, ...
The expansion of the advanced therapy medicinal products market is primarily fueled by the increasing incidence of chronic diseases. The rising prevalence of genetic disorders and cancer, along ...
Pfizer opted to discontinue the product for "several reasons," including limited interest from patients and physicians in gene therapies for hemophilia.
Ten of 11 children born with a rare form of congenital hearing loss experienced improvements after receiving the company’s ...
11hon MSN
Multidrug resistance in cancer can be overcome by combining a drug that blocks a key enzyme with another anticancer drug, ...
A novel scientific method developed at Tel Aviv University promises to accelerate our understanding of the gene PTEN, a key ...
Lilly expands its Zepbound vial offering, as HIMS pulls back on semaglutide, and other biotech news in today's Readout ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback